Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Kepler Weber Q1 2026: Mixed ResultsStarbucks cuts 300 US corporate jobsAcumen Pharmaceuticals Beats Q1 2026 EPS ForecastAlico Beats Q2 2026 EPS Forecast by 23%PAVmed Q1 2026: Restructuring Gains HighlightedDavid Beckham becomes UK's first billionaire athleteAI: Threat and OpportunityGulf states refuse to join UAE in operations against IranLifeward strategic moves amid revenue declineWEX stock rises on $1B buyback planKepler Weber Q1 2026: Mixed ResultsStarbucks cuts 300 US corporate jobsAcumen Pharmaceuticals Beats Q1 2026 EPS ForecastAlico Beats Q2 2026 EPS Forecast by 23%PAVmed Q1 2026: Restructuring Gains HighlightedDavid Beckham becomes UK's first billionaire athleteAI: Threat and OpportunityGulf states refuse to join UAE in operations against IranLifeward strategic moves amid revenue declineWEX stock rises on $1B buyback plan
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#cellebrite

Latest news and interesting information about cellebrite.

Needham Cuts Cellebrite Target to $15 on Valuation
Today / 12:02
|
275

Needham Cuts Cellebrite Target to $15 on Valuation

Needham lowered Cellebrite price target to $15 from $18, maintaining Buy. Strong Q1 results, growth products doubling, and FedRAMP authorization highlight the company's performance.

ANALYST RATINGS →
0
...